Ann: PAR REPORTS SUCCESSFUL ROSS RIVER PHASE 2 CLINICAL TRIAL, page-18

First 18 Last

Share
Profile

Follow
hercules007

4,525 Posts.

110

05/06/19

13:28

Post #: 38920036
Share

Originally posted by Mozzarc ↑

Im still amazed at how good that news is...RRV and thus potentially Chikungunya (CHIKV), the numbers are compelling 5000 cases of RRV in Australia alone, worldwide this would be a few more...but CHIKV is in the millions..I personally know people that have had it or know of others that have had it.
Of course PAR may only attract a fraction of these, but imagine the numbers involved if only 5% take it up. Im sure it would eventually be more like 15%.

To think that WE have the only viable solution and it results in a quick remedy. Currently, "The best means of prevention is overall mosquito control and the avoidance of bites in areas where the disease is common". Paracetamol is the only thing that is suggested as a relief, not a viable solution over weeks, sometimes months of the infliction.

As shareholders the ONLY thing we need is a fair dollop of patience now...it will be a while still before this hits the market on a commercial scale, I'm guessing we still need to go through the Phase 3 hurdle for this separately (Separate to OA Phase 3) but I'm hoping/guessing it will be a reduced pathway in terms of time as they are related in terms of joint pain and formulation etc.

As 51Cap have mentioned (its emblazoned in my mind), if PAR have positive results from all three main indications, OA, RRV AND MPS, the share price could easily one day see north of $30. This is becoming a reality for us.

Remember, my opinions expressed here, better to do your own research.

1. https://en.wikipedia.org/wiki/Chikungunya

Expand

"north of $30"

Was it no "north of $300 rather"?

PAR Price at posting: $1.48 Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

What's causing the cost-of-living crisis, and how to navigate it

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

M4M

Macro, Norden set up transport solutions initiative for West Pilbara